Golden Biotechnology Financials
| 4132 Stock | TWD 16.50 0.15 0.92% |
Golden |
Understanding current and past Golden Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Golden Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Golden Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Golden Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Golden Biotechnology. Check Golden Biotechnology's Beneish M Score to see the likelihood of Golden Biotechnology's management manipulating its earnings.
Golden Biotechnology Stock Summary
Golden Biotechnology competes with Grape King, ScinoPharm Taiwan, YungShin Global, Standard Chemical, and SCI Pharmtech. Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company. Golden Biotechnology Corporation was founded in 2002 and is based in New Taipei City, Taiwan. GOLDEN BIOTECHNOLOGY operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 135 people.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Business Address | No27-6, Zhongzheng East |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.goldenbiotech.com.tw |
| Phone | 886 2 2808 6006 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Golden Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Golden Stock, because this is throwing your money away. Analyzing the key information contained in Golden Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Golden Biotechnology Key Financial Ratios
There are many critical financial ratios that Golden Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Golden Biotechnology reports annually and quarterly.| Return On Equity | -36.95 | |||
| Return On Asset | -17.85 | |||
| Number Of Employees | 135 | |||
| Beta | 0.72 | |||
| Z Score | 13.2 |
Golden Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Golden Biotechnology's current stock value. Our valuation model uses many indicators to compare Golden Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Golden Biotechnology competition to find correlations between indicators driving Golden Biotechnology's intrinsic value. More Info.Golden Biotechnology is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Golden Biotechnology's earnings, one of the primary drivers of an investment's value.Golden Biotechnology Systematic Risk
Golden Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Golden Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Golden Biotechnology correlated with the market. If Beta is less than 0 Golden Biotechnology generally moves in the opposite direction as compared to the market. If Golden Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Golden Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Golden Biotechnology is generally in the same direction as the market. If Beta > 1 Golden Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Golden Biotechnology Thematic Clasifications
Golden Biotechnology is part of several thematic ideas from Biotech to Computers. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasGolden Biotechnology November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Golden Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Golden Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Golden Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Golden Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Golden Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 19.95 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 1.75 |
Additional Tools for Golden Stock Analysis
When running Golden Biotechnology's price analysis, check to measure Golden Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Golden Biotechnology is operating at the current time. Most of Golden Biotechnology's value examination focuses on studying past and present price action to predict the probability of Golden Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Golden Biotechnology's price. Additionally, you may evaluate how the addition of Golden Biotechnology to your portfolios can decrease your overall portfolio volatility.